Industry News

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Automotive
Chemicals
Events
Food and Beverages
Healthcare- Biotechnology
Healthcare- Medical Devices
ICT
News

WHO: Pretreatment HIV drug resistance exceeds

The drug-resistant form of the virus has been detected at unacceptable levels across Africa, Asia and the Americas.

Researchers build artificial cells that sense and respond to their environment

Scientists have created artificial cells that mimic biological cells by responding to a chemical change in their surroundings.

Search for new semiconductors heats up with gallium oxide

Electrical engineers have cleared another hurdle in high-power semiconductor fabrication by adding the field’s hottest material — beta-gallium oxide — to their arsenal. Beta-gallium oxide is readily available and promises to convert power faster and more efficiently than today’s leading semiconductor materials — gallium nitride and silicon, the researchers said.

Semi synthetic bacteria: New insights for understanding genetic code

Synthetic biologists seek to create new life with forms and functions not seen in nature. Although scientists are a long way from making a completely artificial life form, they have made semi-synthetic organisms that have an expanded genetic code, allowing them to produce never-before-seen proteins.

Bosch sells packaging machinery division to CVC Capital Partners

Bosch has agreed to sell its packaging machinery division to private equity firm CVC Capital Partners for an undisclosed sum.

Another Alzheimer’s setback as Amgen, Novartis abandon BACE inhibitor trial

After a review of clinical data from the Generation Program studies, Novartis, Amgen and Banner Alzheimer’s Institute have decided to discontinue investigation of the BACE1 inhibitor CNP520 (umibecestat) in two pivotal Phase II/III studies in the Alzheimer’s Prevention Initiative Generation Program.

Orphan Drug Designation granted for AZ’ Imfinzi

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Imfinzi (durvalumab) for the treatment of small cell lung cancer (SCLC).

LBB Specialties subsidiary acquires Custom Ingredients

LBB Specialties subsidiary Charkit Chemical Company has acquired Custom Ingredients, a manufacturer of speciality ingredients, and CA Specialities, a South Carolina-based distributor of ingredients for the personal care market.

New Immunotherapy approach aiming to improve cancer patients lifestyle

Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.

 

Adopting Eggshells as a promising candidate for biomedical engineering

Eggshells can enhance the growth of new, strong bones needed in medical procedures, a team of UMass Lowell researchers has discovered.

Subscribe to Newsletter

IEBS Insights

Case Studies